Concepedia

Publication | Open Access

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

381

Citations

14

References

2017

Year

References

YearCitations

Page 1